登录后 PLUS 会员 可查看完整内容
微信扫一扫
成为会员后
查看完整内容
文献评审日期:2022-06-15
1. Ferris RL, Blumenschein G, et al. Nivolumab for recurrent squamous-cell carcinoma of the head and neck. New England Journal of Medicine 2016;375:1856–67.
2. Ready N, Farago AF, et al. Third-Line nivolumab monotherapy in recurrent SCLC: CheckMate 032. Journal of Thoracic Oncology 2019;14:237–44.
3. Hargadon KM, Johnson CE, Williams CJ. Immune checkpoint blockade therapy for cancer: an overview of FDA-approved immune checkpoint inhibitors. Int Immunopharmacol 2018;62:29–39.
2021 SITC临床实践指南:免疫检查点抑制剂相关不良事件
《中国中性粒细胞缺乏伴发热患者抗菌药物临床应用指南(2020年版)》解读
免疫检查点抑制剂引起的内分泌系统免疫相关不良反应专家共识(2020)